Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva, Maker of Generic Drugs, Bids $40 Billion to Acquire Its Rival Mylan - The New York Times
Teva or Mylan: Who Has the More Promising Revenue Trajectory?
Lawmakers to Teva, Mylan: Stop stonewalling our price-fixing probe | Fierce Pharma
Mylan NV and Teva Pharmaceutical Industries Ltd decline as report says generic-drug companies face probe of alleged price fixing
$40B deal: Teva offers to buy Mylan
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
Generic Drugmakers Mylan and Teva Face Antitrust Complaint
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Valsartan recall expands to Mylan, Teva products | Fierce Pharma
Teva-Makes-Hostile-Bid-Acquire
Mylan surprises analysts, Teva with long-delayed Copaxone approvals | Fierce Pharma
Mylan rejects Teva takeover bid as too low | Mint
Mylan Rejects Teva Buyout Offer
Drugmaker Teva makes $40B bid for rival Mylan
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva Offers to acquire Mylan for $40 billion in cash, stock | Pharma Companies
Teva Pharmaceutical Gains Approval For Generic EpiPen, Mylan Shares Flat
